$522.70
0.10% today
NYSE, Feb 28, 05:13 pm CET
ISIN
US8835561023
Symbol
TMO

Thermo Fisher Scientific Stock price

$523.23
-60.41 10.35% 1M
-87.17 14.28% 6M
+3.00 0.58% YTD
-42.94 7.58% 1Y
-20.77 3.82% 3Y
+226.15 76.12% 5Y
+393.23 302.48% 10Y
NYSE, Closing price Thu, Feb 27 2025
-10.06 1.89%
ISIN
US8835561023
Symbol
TMO
Sector

Key metrics

Market capitalization $197.39b
Enterprise Value $224.68b
P/E (TTM) P/E ratio 31.67
EV/FCF (TTM) EV/FCF 30.92
EV/Sales (TTM) EV/Sales 5.24
P/S ratio (TTM) P/S ratio 4.60
P/B ratio (TTM) P/B ratio 4.02
Dividend yield 0.30%
Last dividend (FY24) $1.56
Revenue growth (TTM) Revenue growth 0.05%
Revenue (TTM) Revenue $42.88b
EBIT (operating result TTM) EBIT $7.66b
Free Cash Flow (TTM) Free Cash Flow $7.27b
Cash position $5.58b
EPS (TTM) EPS $16.52
P/E forward 27.89
P/S forward 4.50
EV/Sales forward 5.12
Short interest 1.03%
Show more

Is Thermo Fisher Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Thermo Fisher Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Thermo Fisher Scientific forecast:

26x Buy
81%
6x Hold
19%

Analyst Opinions

32 Analysts have issued a Thermo Fisher Scientific forecast:

Buy
81%
Hold
19%

Financial data from Thermo Fisher Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
42,879 42,879
0% 0%
100%
- Direct Costs 25,508 25,508
2% 2%
59%
17,371 17,371
4% 4%
41%
- Selling and Administrative Expenses 5,211 5,211
15% 15%
12%
- Research and Development Expense 1,390 1,390
4% 4%
3%
10,770 10,770
1% 1%
25%
- Depreciation and Amortization 3,108 3,108
9% 9%
7%
EBIT (Operating Income) EBIT 7,662 7,662
3% 3%
18%
Net Profit 6,335 6,335
6% 6%
15%

In millions USD.

Don't miss a Thing! We will send you all news about Thermo Fisher Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Thermo Fisher Scientific Stock News

Neutral
GlobeNewsWire
2 days ago
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company's largest active shareholder, commented on Solventum's recently announced sale of its Purification & Filtration business to Thermo Fisher Scientific Inc (NYSE: TMO) (“Thermo Fisher”). Trian issued t...
Neutral
Business Wire
2 days ago
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus Registry.
Positive
Reuters
3 days ago
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion.
More Thermo Fisher Scientific News

Company Profile

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Head office United States
CEO Marc Casper
Employees 125,000
Founded 1960
Website www.thermofisher.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today